Biotech

All Articles

Rakovina strengthens AI concentrate along with collab to select cancer aim ats

.5 months after Rakovina Rehabs pivoted toward expert system, the cancer-focused biotech has actuall...

Ascendis' dwarfism drug smash hits in phase 3, threatens BioMarin

.Ascendis Pharma has emerged as a potential hazard to BioMarin's Voxzogo, stating phase 3 developmen...

Despite ph. 3 miss, Alkeus finds course ahead for eye illness asset

.Though Alkeus Pharmaceuticals' oral eye ailment property fell short to considerably reduce geograph...

Kairos goes social with $6M IPO to cash trials of cancer drug

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was very easy to miss a smaller-sc...

Vaccine as well as Keytruda combination efficient in squamous cell carcinoma

.Immune gate inhibitors are actually the superheroes of cancer therapy. Drugs like Bristol Myers Squ...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable management hirings, shootings...

Regeneron's Opdualag opponent reveals 57% reaction cost

.Regeneron is back along with long-term follow-up for its own LAG-3 inhibitor and PD-1 prevention co...

AstraZeneca articles records on in-house competitors to AbbVie, Pfizer ADCs

.AstraZeneca has discussed an early look at the performance of its in-house antibody-drug conjugate ...

iTeos- GSK's TIGIT superstar presents purposeful remodeling

.After revealing a period 3 launch based on good midstage outcomes, iTeos and also GSK are actually ...

More collaborative FDA can speed up rare condition R&ampD: record

.The FDA ought to be more open and also collective to discharge a surge in commendations of uncommon...